Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 1:49 PM
Ignite Modification Date:
2025-12-24 @ 1:49 PM
NCT ID:
NCT02624895
Eligibility Criteria:
Inclusion Criteria:- Adult (\>= 18 years old) RAS wild-type metastatic colorectal cancer patients candidate to receive FOLFOX or FOLFIRI plus panitumumab or FOLFOX or FOLFIRI plus cetuximab as upfront treatment as per clinical practice
* Willingness and ability to comply with the protocol
* Written informed consent to study procedures
* Exclusion Criteria: - Patients receiving a treatment under clinical investigation may not be included in the study
* Previous treatment with an anti-EGFR monoclonal antibody
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02624895
Study Brief:
Protocol Section:
NCT02624895